Introduction {#S0001}
============

Stroke is the main cause of death in China,[@CIT0001] with ischemic stroke to be the most common subtype.[@CIT0002] Ischemic stroke is a type of arteriosclerotic disease and a heterogeneous disease.[@CIT0003] Studies have shown that elevated blood pressure, age, obesity, smoking, hyperlipidemia, impaired fasting glucose, elevated fasting blood glucose (FBG), diabetes and hyperglycemia were independent risk factors for ischemic stroke.[@CIT0003] Although previous studies have reported significant associations between FBG and arteriosclerotic cardiovascular disease,[@CIT0004]--[@CIT0007] the relationship between FBG and ischemic stroke was still controversial. Some studies reported that the relationship between stroke and FBG was linear, U-shaped or J-shaped among general population,[@CIT0008] asymptomatic adults,[@CIT0009] patients with pre-existing atherothrombotic diseases,[@CIT0010] or non-diabetic population.[@CIT0006],[@CIT0011] In addition, there was a study demonstrated that FBG had no null association with the risk of cardiovascular diseases, such as coronary heart disease and ischemic stroke in hypertensive patients.[@CIT0012] Given the inconsistent relationship between fasting blood glucose and first ischemic stroke in older adults with hypertension, we explored the association among older hypertensive patients with hypertension in China.

Materials and Methods {#S0002}
=====================

Study Subjects {#S0002-S2001}
--------------

This retrospective cohort study enrolled 3500 older patients from January, 2010, to December, 2011, at Guangdong community in China. We recruited essential hypertensive patients who were at least 60 years of age. We excluded participants with missing data on blood pressure (n=37), FBG (n=5) or physical examination (n=16), and those who had a stroke history at baseline (n=132). Eventually, 3310 participants were included for data analysis ([Figure 1](#F0001){ref-type="fig"}). Informed consent was obtained from all included participants. This study was in compliance with the principles outlined in the Declaration of Helsinki and was approved by the institutional medical ethical committee the Guangdong Provincial People's Hospital, Guangzhou, China.Figure 1Research flow chart.

Measurement of Indicators {#S0002-S2002}
-------------------------

Demographic information was obtained from all patients through questionnaires, including age, sex, habits on smoking and drinking, a previous history of diseases (such as diabetes, coronary heart disease, and stroke), and combined medication history (such as antihypertensive drugs, hypoglycemic drugs, and lipid-lowering drugs). Parameters being measured in the physical examination and laboratory tests included height, weight, and blood pressure, urinalysis, FBG, blood lipid and creatinine after overnight fasting. Drinking status was defined as having consumed at least 50g alcohol daily in the last 30 days and smoking was defined as using at least 100 cigarettes during their lifetime in the last 30 days before the survey of the present study.[@CIT0013] Hypertension was defined as systolic blood pressure (SBP) ≥140 mmHg or/and diastolic blood pressure (DBP) ≥ 90 mmHg, or currently taking antihypertensive medication or self-reported.[@CIT0014] Diabetes was defined as FBG ≥11.1 mmol/L, or currently taking hypoglycemic agents or self-reported.[@CIT0015] Body mass index (BMI) was calculated as the weight in kilograms divided by the height in meters squared. Estimate glomerular filtration rate (eGFR) was calculated by using the simplified equation on the modification of diet.

All stroke cases were ascertained from the local medical insurance system of the medical insurance bureau, and patients without medical records were followed up by telephone or by face- to- face in the community until 31 December 2016. Hospitalization with a diagnosis of ischemic stroke was confirmed by computed tomography or magnetic resonance image and checked by discharge data.

Statistical Analysis {#S0002-S2003}
--------------------

All the continuous variables were presented as mean ± standard deviation, and categorical variables were presented in frequency or as a percentage according to baseline FBG categories. FBG concentrations were grouped by quartiles (Q1: \< 4.39mmol/l, Q2: 4.40--5.79 mmol/l, Q3: 5.80--6.36 mmol/l, and Q4: ≥6.37 mmol/l). Subgroup differences by FBG quartiles were identified by the One-Way ANOVA, Kruskal--Wallis *H*-test and chi-square tests. Hazard ratios (HRs) and 95% confidence intervals (CIs) for ischemic stroke were estimated using multivariate Cox regression analysis. The Model I only included FBG. The model II was adjusted for age, sex and BMI. The model III was adjusted for sex, BMI, age, diabetes history, coronary heart disease history, antihypertensive drugs, statins, SBP, DBP, triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), smoking, drinking and eGFR. Subgroup analysis was conducted according to sex (male or female), age (\<70, 70--80 or ≥80 years), SBP (\<140 or ≥140 mm Hg), eGFR (\<90 or ≥90 mL/min/1.73m^2^), BMI (\<25 or ≥25 kg/m^2^), the history of diabetes (yes or no), drinking status (yes or no), smoking status (yes or no), using statins (yes or no) and taking antihypertensive drug (yes or no), and the interactions between FBG and subgroups on the association with stroke were tested. A 2-sided P\<0.05 was considered statistically significant. All statistical analyses were performed using R version 3.3.2 (R Foundation for Statistical Computing, Vienna, Austria).

Results {#S0003}
=======

Characteristics of the Participants {#S0003-S2001}
-----------------------------------

After applying the inclusion and exclusion criteria, 3310 older hypertensive patients were included, 1474 (44.53%) were males. The mean age was 71.41 ± 7.20 years old. Baseline characteristics of the participants are presented in [Table 1](#T0001){ref-type="table"}. There were significant differences in age, BMI, SBP, DBP, triglyceride, LDL-C, HDL-C, sex, smoking status, diabetes history and taking antihypertensive drugs and statins across the quartile groups.Table 1Baseline Characteristics of Participant Patients by Quartiles of Fasting Blood GlucoseAllQ1Q2Q3Q4P-valueNumber3310810(\<4.39mmol/l)836(4.40--5.79 mmol/l)829(5.80--6.36 mmol/l)835(≥6.37 mmol/l)Age(years)71.41 ± 7.2072.25 ± 7.0671.61 ± 7.0171.40 ± 7.0970.39 ± 7.50\<0.001BMI(kg/m^2^)23.91 ± 3.8023.30 ± 3.7223.36 ± 3.4423.94 ± 3.6324.03 ± 4.14\<0.001SBP(mmHg)131.08 ± 17.23128.47 ± 15.76129.94 ± 16.99132.02 ± 17.36133.83 ± 18.23\<0.001DBP(mmHg)78.33 ± 9.5577.47 ± 9.1978.05 ± 9.5378.58 ± 9.5479.21 ± 9.850.002TC(mg/dl)203.07 ± 45.66203.28 ± 47.84204.31 ± 42.27202.19 ± 43.43202.50 ± 48.880.791Triglyceride (mg/dl)150.11 ± 116.12136.15 ± 114.06136.80 ± 95.11147.48 ± 107.17180.39 ± 138.77\<0.001LDL-C(mg/dl)103.63 ± 29.43102.52 ± 27.95105.04 ± 29.19105.09 ± 29.89101.85 ± 30.550.047HDL-C(mg/dl)50.76 ± 14.0351.31 ± 16.7151.51 ± 12.7850.83 ± 13.0349.38 ± 13.150.010eGFR(mL/min/1.73m^2^)90.42 ± 34.2191.95 ± 39.4988.29 ± 36.6586.60 ± 30.7094.82 ±37.490.426Sex(n, %)0.002 Male1474 (44.53%)388 (47.90%)396 (47.37%)360 (43.43%)330 (39.52%) Female1836 (55.47%)422 (52.10%)440 (52.63%)469 (56.57%)505 (60.48%)Smoking(n, %)0.002 No2377 (71.81%)552 (68.15%)582 (69.62%)610 (73.58%)633 (75.81%) Yes933 (28.19%)258 (31.85%)254 (30.38%)219 (26.42%)202 (24.19%)Drinking(n, %)0.719 No2972 (89.79%)730 (90.12%)742 (88.76%)746 (89.99%)754 (90.30%) Yes338 (10.21%)80 (9.88%)94 (11.24%)83 (10.01%)81 (9.70%)Diabetes(n, %)\<0.001 No2805 (84.74%)771 (95.19%)781 (93.42%)747 (90.11%)506 (60.60%) Yes505 (15.26%)39 (4.81%)55 (6.58%)82 (9.89%)329 (39.40%)CAD(n, %)0.352 No3276 (98.97%)804 (99.26%)828 (99.04%)822 (99.16%)822 (98.44%) Yes34 (1.03%)6 (0.74%)8 (0.96%)7 (0.84%)13 (1.56%)Antihypertensive drugs(n, %)\<0.001 No2158 (65.20%)584 (72.10%)579 (69.26%)531 (64.05%)464 (55.57%) Yes1152 (34.80%)226 (27.90%)257 (30.74%)298 (35.95%)371 (44.43%)Beta-blocker(n, %)\<0.001 No3155 (95.32%)778 (96.05%)808 (96.65%)797 (96.14%)772 (92.46%) Yes155 (4.68%)32 (3.95%)28 (3.35%)32 (3.86%)63 (7.54%)CCB(n, %)\<0.001 No2656 (80.24%)693 (85.56%)692 (82.78%)654 (78.89%)617 (73.89%) Yes654 (19.76%)117 (14.44%)144 (17.22%)175 (21.11%)218 (26.11%)ACEI(n, %)0.006 No3099 (93.63%)775 (95.68%)789 (94.38%)769 (92.76%)766 (91.74%) Yes211 (6.37%)35 (4.32%)47 (5.62%)60 (7.24%)69 (8.26%)ARB(n, %)\<0.001 No2667 (80.57%)676 (83.46%)699 (83.61%)657 (79.25%)635 (76.05%) Yes643 (19.43%)134 (16.54%)137 (16.39%)172 (20.75%)200 (23.95%)Statins(n, %)\<0.001 No3025 (91.39%)752 (92.84%)771 (92.22%)771 (93.00%)731 (87.54%) Yes285 (8.61%)58 (7.16%)65 (7.78%)58 (7.00%)104 (12.46%)[^2]

The Relationship Between Fasting Blood Glucose Levels and Ischemic Stroke {#S0003-S2002}
-------------------------------------------------------------------------

As showed in [Table 2](#T0002){ref-type="table"}, during an average follow-up of 5.5 years, 206 cases of ischemic strokes occurred. When FBG was treated as continuous variable, FBG was significantly associated with ischemic stroke in model I (HR=1.15, 95% CI: 1.08, 1.23; P\<0.001). In model II, FBG was still an independent risk factor for ischemic stroke (HR=1.14, 95% CI: 1.07, 1.23; P\<0.001), as well as the fully adjusted model (model III), where FBG (HR=1.11, 95% CI: 1.03, 1.21; P=0.008) was positively associated with the first occurrence of ischemic stroke ([Table 2](#T0002){ref-type="table"}). When using the lowest quartile of FBG as reference, the HRs for ischemic stroke from Q2 to Q4 were 1.77 (95% CI: 1.10, 2.87, 1.90 (95% CI: 1.18, 3.07) and 3.08 (95% CI: 1.97, 4.83) (P for trend\<0.001) in model I. In model III, the HRs for the first occurrence of ischemic stroke increased in parallel with the quartiles of FBG (HRs were 1.76 (95% CI: 1.08, 2.86), 1.73 (95% CI: 1.06, 2.81), and 2.42 (95% CI: 1.49, 3.93) from the second to the fourth quartiles, respectively, P for trend\<0.001) ([Table 2](#T0002){ref-type="table"}). Multivariate adjusted smoothing spline plots suggested that FBG levels have a nonlinear relationship with the first occurrence of ischemic stroke ([Figure 2](#F0002){ref-type="fig"}).Table 2Relationship Between Fasting Blood Glucose Levels and the First Occurrence of Ischemic Stroke in Different ModelsModel IModel IIModel IIICase/TotalHR(95% CI) P-valueHR(95% CI) P-valueHR(95% CI) P-valueFBG(per SD increased)206/33101.15 (1.08, 1.23) \<0.0011.14 (1.07, 1.23) \<0.0011.11 (1.03, 1.21) 0.008FBG (quartile) Q127/810refrefref Q248/8361.77 (1.10, 2.87) 0.0191.79 (1.10, 2.90) 0.0181.76 (1.08, 2.86) 0.023 Q351/8291.90 (1.18, 3.07) 0.0081.87 (1.16, 3.02) 0.0101.73 (1.06, 2.81) 0.027 Q480/8353.08 (1.97, 4.83) \<0.0012.89 (1.83, 4.55) \<0.0012.42 (1.49, 3.93) \<0.001P for trend\<0.001\<0.001\<0.001[^3][^4] Figure 2The relationship between fasting blood glucose levels and the first occurrence of ischemic stroke.**Abbreviations:** FBG, fasting blood glucose; HR, hazard ratios; CI, confidence interval.

The Results of Subgroup Analyses {#S0003-S2003}
--------------------------------

As shown in [Table 3](#T0003){ref-type="table"}, subgroup analysis revealed that the association between FBG and risk of ischemic stroke was appear to be stronger in male (HR: 1.22 vs 1.10), those with uncontrolled hypertension (HR: 1.22 vs 1.10), subjects with diabetes (HR: 1.19 vs 1.10), overweight (HR: 1.19 vs 1.09), smoking habits (HR: 1.33 vs 1.13), drinking habits (HR: 1.17 vs 1.05), without using statins (HR: 1.19 vs 1.09), without taking antihypertensive drugs (HR: 1.16 vs 1.10) and those with eGFR\< 90 (HR: 1.16 vs 1.09).Table 3Effect Size of Fasting Blood Glucose Levels on the First Occurrence of Ischemic Stroke in SubgroupsNumberHR(95% CI)P-valueP InteractionSex0.318 Male14741.22 (1.09, 1.36)\<0.001 Female18361.10 (1.04, 1.23)0.003Age0.298 \<7016401.23 (1.09, 1.38)\<0.001 ≥70, \<8012041.11 (1.01, 1.22)0.037 ≥804661.07 (1.05, 1.46)0.043Diabetes0.084 No28051.10 (1.05, 1.34)0.034 Yes5051.19 (1.07, 1.18)0.002Smoking0.091 No23771.13 (1.05, 1.22)0.001 Yes9331.33 (1.12, 1.57)\<0.001Drinking0.939 No29721.05 (1.08, 1.23)0.031 Yes3381.17 (1.03, 1.53)0.027Taking antihypertensive drugs0.843 No21581.16 (1.08, 1.24)\<0.001 Yes11521.10 (1.04, 1.50)0.033Statins0.571 No30251.19 (1.07, 1.23)0.002 Yes2851.09 (1.04, 1.46)0.040SBP0.458 \<14023561.10 (1.04, 1.35)0.003 ≥1409541.22 (1.06, 1.43)\<0.001BMI0.300 \<2521221.09 (1.02, 1.21)0.005 ≥2511881.19(1.08, 1.32)0.031eGFR0.927 \<9015181.16 (1.04, 1.34)0.008 ≥9017921.09 (1.03, 1.27)0.016[^5][^6]

Discussion {#S0004}
==========

In the present study, elevated FBG levels were significantly associated with increased risk for the first incident of ischemic stroke and this relationship appeared as a gradually increasing nonlinear relationship. The risk might further elevate for subjects combined with diabetes, poorly controlled blood pressure, smoking, being overweight, and with reduced renal function.

We found that the risk for first ischemic stroke gradually increased with FBG concentration. The result of the present study agreed with previous cohort analyses among adults with hypertension.[@CIT0012],[@CIT0016] Our study did not find a clear threshold for the relationship between FBG and ischemic stroke among older adults with hypertension. Our results might suggest a J-curve nor a U-curve relationship, which was also suggested in some other studies.[@CIT0004],[@CIT0008],[@CIT0010],[@CIT0017],[@CIT0018] In addition, a meta-analysis of 102 prospective studies demonstrated that among people without diabetes, FBG concentration had modest and non-linear relation with stroke risk.[@CIT0019] The reason why our research results differ from previous may be due to the selected population and ethnicities of these studies are different.

In our study, older hypertensive patients combined with diabetes, poorly controlled blood pressure, smoking, being overweight, with reduced renal function might have a higher risk for ischemic stroke. Smoking, elevated SBP, obesity and diabetes were established risk factors for ischemic stroke,[@CIT0003] which was likely the explanation for our findings. Our results were also consistent with previous studies[@CIT0020]--[@CIT0023] and current international recommendations for stroke prevention and treatment.[@CIT0003],[@CIT0024] Individuals should stop smoking, limit or avoid alcohol, maintaining good control on weight, blood pressure, blood sugar and blood lipids for stroke prevention.[@CIT0025]--[@CIT0028]

However, some limitations should be taken into consideration in the present study. First, FBG was measured only once at baseline, so we were not able to examine the effects of FBG changes with stroke. Second, we did not adjust for several confounding factors were adjusted, such as the history of atrial fibrillation, the levels of uric acid and homocysteine. Third, the history of diabetes in this study was mainly obtained from self-reported history and we did not have the data of glycated hemoglobin. Finally, the present study did not distinguish the relationship between FBG and different subtypes of stroke.

Conclusion {#S0005}
==========

In conclusion, among elderly hypertensive patients, FBG was closely related to the first occurrence of ischemic stroke. The relationship was stronger for subjects combined with diabetes, poorly controlled blood pressure, smoking, being overweight, and with reduced renal function.
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